Characterization of extended-spectrum-β-lactamases produced by Escherichia coli strains isolated from dogs in Poland

Polish Journal of Microbiology

Volumn 64, Issue 3, 2015, Pages 285-288

  Rzewuska, Magdalena ^a   Stefańska, Ilona ^b   Kizerwetter ͆wida, Magdalena ^a   Chrobak Chmiel, Dorota ^b   Szczygielska, Paulina ^a   Leśniak, Monika ^c   Binek, Marian ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b Prof Wac aw D browski Institute of Agricultural and Food Biotechnology State Research Institute   (Poland)

^c MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

Author keywords

Dog infections; Escherichia coli; Extended spectrum lactamases; Multidrug resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; BETA LACTAMASE SHV 12; BETA LACTAMASE TEM 116; CEFOTAXIME; CEFOVECIN; CEFUROXIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ENROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; FLORFENICOL; GENTAMICIN; MARBOFLOXACIN; NITROFURANTOIN; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DOG; ESCHERICHIA COLI; NONHUMAN; NUCLEOTIDE SEQUENCE; POLAND; VETERINARY CLINIC; ANIMAL; DOG DISEASES; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; VETERINARY;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; POLAND;

EID: 84942251197     PISSN: 17331331     EISSN: 25444646     Source Type: Journal    
DOI: 10.5604/01.3001.0009.2124     Document Type: Article

References (19)

1. Belas A., A.S. Salazar, L.T. Gama, N. Couto and C. Pomba. 2014. Risk factors for faecal colonisation with Escherichia coli producing extended-spectrum and plasmid-mediated AmpC β-lactamases in dogs. Vet. Rec. 175: 202.
2. Briñas L., M. Lantero, I. de Diego, M. Alvarez, M. Zarazaga and C. Torres. 2005. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J. Antimicrob. Chemother. 56: 1107-1110.
3. Carattoli A., S. Lovari, A. Franco, G. Cordaro, P. Di Matteo and A. Battisti. 2005. Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob. Agents Chemother. 49: 833-835.
4. CLSI. 2013. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals; Second Informational Supplement. CLSI document VET01-S2. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Coque T.M., A. Oliver, J.C. Pérez-Díaz, F. Baquero and R. Cantón. 2002. Genes encoding TEM-4, SHV-2 and CTX-M-10 extended-spectrum β-Lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob. Agents Chemother. 46: 500-510.
6. Costa D., P. Poeta, Y. Sáenz, A.C. Coelho, M. Matos, L. Vinué, J. Rodrigues and C. Torres. 2008. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets. Vet. Microbiol. 127:97-105.
7. Dhara L., A. Tripathi and A. Pal. 2013. Molecular characterization and in silico analysis of naturally occurring TEM beta-lactamase variants among pathogenic Enterobacteriaceae infecting Indian patients. Biomed Res Int. 2013: Article ID 783540.
8. Dierikx C.M., E. van Duijkeren, A.H. Schoormans, A. van Essen-Zandbergen, K. Veldman, A. Kant, X.W. Huijsdens, K. van der Zwaluw, J.A. Wagenaar and D.J. Mevius. 2012. Occurrence and characteristics of extended-spectrum-β-lactamase-and AmpC-producing clinical isolates derived from companion animals and horses. J. Antimicrob. Chemother. 67: 1368-1374.
9. Ewers C., M. Grobbel, I. Stamm, P.A. Kopp, I. Diehl, T. Semmler, A. Fruth, J. Beutlich, B. Guerra, L.H. Wieler and others. 2010. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65: 651-660.
10. Hordijk J., A. Schoormans, M. Kwakernaak, B. Duim, E. Broens, C. Dierikx, D. Mevius and J.A. Wagenaar. 2013. High prevalence of fecal carriage of extended spectrum β-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs. Front. Microbiol. 4: 242.
11. Huber H., C. Zweifel, M.M. Wittenbrink and R. Stephan. 2013. ESBL-producing uropathogenic Escherichia coli isolated from dogs and cats in Switzerland. Vet. Microbiol. 162: 992-996.
12. Murphy C.P., R.J. Reid-Smith, P. Boerlin, J.S. Weese, J.F. Prescott, N. Janecko and S.A. McEwen. 2012. Out-patient antimicrobial drug use in dogs and cats for new disease events from community companion animal practices in Ontario. Can. Vet. J. 53: 291-298.
13. O'Keefe A., T.A. Hutton, D.M. Schifferli and S.C. Rankin. 2010. First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob. Agents Chemother. 54: 3489-3492.
14. Rubin J.E. and J.D.D. Pitout. 2014. Extended-spectrum β-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals. Vet. Microbiol. 170: 10-18.
15. Rzewuska M, M. Czopowicz, M. Kizerwetter-͆wida, D. Chrobak, B. Błaszczak and M. Binek. 2015. Multidrug resistance in Escherichia coli strains isolated from infections in dogs and cats in Poland (2007-2013) The Scientific World Journal 2015: Article ID 408205.
16. Schmiedel J., L. Falgenhauer, E. Domann, R. Bauerfeind, E. Prenger-Berninghoff, C. Imirzalioglu and T. Chakraborty. 2014. Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany. BMC Microbiol. 14: 187.
17. Shaheen B.W., R. Nayak, S.L. Foley, O. Kweon, J. Deck, M. Park, F. Rafii and D.M. Boothe. 2011. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States. Antimicrob. Agents Chemother. 55: 5666-5675.
18. So J.H., J. Kim, I.K. Bae, S.H. Jeong, S.H. Kim, S.K. Lim, Y.H. Park and K. Lee. 2012. Dissemination of multidrug-resistant Escherichia coli in Korean veterinary hospitals. Diagn. Microbiol. Infect. Dis. 73: 195-199.
19. Thomson K.S. 2010. Extended-Spectrum-β-Lactamase, AmpC and Carbapenemase Issues. J. Clin. Microbiol. 48: 1019-1025.